Equilibra Bioscience
Phase 1Equilibra Bioscience is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-activated Protein C (APC) monoclonal antibody (mAb) therapeutic for inherited and/or acquired bleeding disorders including Hemophilia A/B.
Founded
2018
Focus
AntibodiesBiologics
About
Equilibra Bioscience is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-activated Protein C (APC) monoclonal antibody (mAb) therapeutic for inherited and/or acquired bleeding disorders including Hemophilia A/B.
Funding History
1Total raised: $3.8M
Seed$3.8MUndisclosedMay 15, 2022
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile